Adjuvant Palbociclib in Elderly Patients With Breast Cancer

NCT03609047 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

366

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer Stage II
Breast Cancer Stage III

Interventions

DRUG: Palbociclib
DRUG: Docetaxel / cyclophosphamide
DRUG: doxorubicin/cyclophosphamide
DRUG: epirubicin/cyclophosphamide
DRUG: paclitaxel

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]